BioCentury
ARTICLE | Company News

Astrimmune Ltd., London Genetics Ltd. deal

November 22, 2010 8:00 AM UTC

London Genetics partnered with Astrimmune to identify biomarkers that will identify patients most likely to benefit from Astrimmune's preclinical pancreatic cancer vaccine. Astrimmune said it is provi...